Itamar Medical Ltd (ITMR) Fundamental Analysis & Valuation

NASDAQ:ITMR

Current stock price

30.87
+0.25 (+0.82%)
At close:
30.85
-0.02 (-0.06%)
After Hours:

This ITMR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ITMR Profitability Analysis

1.1 Basic Checks

  • In the past year ITMR has reported negative net income.
ITMR Yearly Net Income VS EBIT VS OCF VS FCFITMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA -20.71%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ITMR Yearly ROA, ROE, ROICITMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 -100 -200 -300

1.3 Margins

Industry RankSector Rank
OM -35.74%
PM (TTM) -41.66%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ITMR Yearly Profit, Operating, Gross MarginsITMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ITMR Health Analysis

2.1 Basic Checks

  • ITMR has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, ITMR has an improved debt to assets ratio.
ITMR Yearly Shares OutstandingITMR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 100M 200M 300M 400M
ITMR Yearly Total Debt VS Total AssetsITMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 20M 40M 60M

2.2 Solvency

  • ITMR has an Altman-Z score of 275.25. This indicates that ITMR is financially healthy and has little risk of bankruptcy at the moment.
  • ITMR has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 275.25
ROIC/WACCN/A
WACCN/A
ITMR Yearly LT Debt VS Equity VS FCFITMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 10M -10M 20M 30M 40M

2.3 Liquidity

  • ITMR has a Current Ratio of 4.12. This indicates that ITMR is financially healthy and has no problem in meeting its short term obligations.
  • A Quick Ratio of 3.78 indicates that ITMR has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 4.12
Quick Ratio 3.78
ITMR Yearly Current Assets VS Current LiabilitesITMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ITMR Growth Analysis

3.1 Past

  • The earnings per share for ITMR have decreased strongly by -100.67% in the last year.
  • Looking at the last year, ITMR shows a very strong growth in Revenue. The Revenue has grown by 33.79%.
  • ITMR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.54% yearly.
EPS 1Y (TTM)-100.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-149.19%
Revenue 1Y (TTM)33.79%
Revenue growth 3Y25.62%
Revenue growth 5Y19.54%
Sales Q2Q%23.34%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ITMR Yearly Revenue VS EstimatesITMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M

More info and screens

Find the best growth stocksShow best growing peers

0

4. ITMR Valuation Analysis

4.1 Price/Earnings Ratio

  • ITMR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ITMR Price Earnings VS Forward Price EarningsITMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -859.6
ITMR Per share dataITMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ITMR Dividend Analysis

5.1 Amount

  • No dividends for ITMR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ITMR Fundamentals: All Metrics, Ratios and Statistics

Itamar Medical Ltd

NASDAQ:ITMR (12/15/2021, 8:36:08 PM)

After market: 30.85 -0.02 (-0.06%)

30.87

+0.25 (+0.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-16
Earnings (Next)03-01
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.09B
Revenue(TTM)50.88M
Net Income(TTM)-21.19M
Analysts85
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 257.28
P/FCF N/A
P/OCF N/A
P/B 177.05
P/tB N/A
EV/EBITDA -859.6
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.12
BVpS0.17
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.71%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -35.74%
PM (TTM) -41.66%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.12
Quick Ratio 3.78
Altman-Z 275.25
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-149.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)33.79%
Revenue growth 3Y25.62%
Revenue growth 5Y19.54%
Sales Q2Q%23.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Itamar Medical Ltd / ITMR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of Itamar Medical Ltd (ITMR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ITMR.


Can you provide the valuation status for Itamar Medical Ltd?

ChartMill assigns a valuation rating of 0 / 10 to Itamar Medical Ltd (ITMR). This can be considered as Overvalued.


Can you provide the profitability details for Itamar Medical Ltd?

Itamar Medical Ltd (ITMR) has a profitability rating of 1 / 10.


How financially healthy is Itamar Medical Ltd?

The financial health rating of Itamar Medical Ltd (ITMR) is 6 / 10.